Yi-an Ko
Melbourne, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Prevalence and clinical significance of co-existing mutations in MED12 and FH in uterine fibroids of Australian women.
Journal: Frontiers in reproductive health
Published: October 26, 2022
Correction to: Clinical implications of prospective genomic profiling of metastatic breast cancer patients.
Journal: Breast cancer research : BCR
Published: July 15, 2022
Population-based BRCA1/2 testing programmes are highly acceptable in the Jewish community: results of the JeneScreen Study.
Journal: Journal of medical genetics
Published: February 17, 2022
Alpelisib Monotherapy for PI3K-Altered, Pretreated Advanced Breast Cancer: A Phase II Study.
Journal: Cancer discovery
Published: December 30, 2021
Proteomic and functional characterization of intra-tumor heterogeneity in human endometrial cancer.
Journal: Cell reports. Medicine
Published: November 02, 2021
Evaluation of two population screening programmes for BRCA1/2 founder mutations in the Australian Jewish community: a protocol paper.
Journal: BMJ open
Published: June 26, 2021
Clinical implications of prospective genomic profiling of metastatic breast cancer patients.
Journal: Breast cancer research : BCR
Published: May 11, 2020
Clinical Utility of Real-Time Targeted Molecular Profiling in the Clinical Management of Ovarian Cancer: The ALLOCATE Study.
Journal: JCO precision oncology
Published: December 01, 2019
Extracellular matrix (ECM) activates β-catenin signaling in uterine fibroids.
Journal: Reproduction (Cambridge, England)
Published: June 05, 2017
Last Updated: 09/26/2026